- Home
- Products
- Customized ADCs
- TNFRSF8
- Anti-TNFRSF8 (cCA10)-β-glucuronide-MMAF ADC
Anti-TNFRSF8 (cCA10)-β-glucuronide-MMAF ADC (CAT#: ADC-W-352)
This ADC product is comprised of an anti-TNFRSF8 monoclonal antibody (cCA10) conjugated via a β-glucuronide linker to a MMAF. The MMAF is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within the cell, MMAF binds to tubulins, interrupts microtubule dynamics, and subsequently, induces cell death.
- ADC Target
- ADC Antibody
- ADC Linker
- ADC payload drug
- Name
- TNFRSF8
- Alternative Names
- TNFRSF8; tumor necrosis factor receptor superfamily, member 8; CD30; Ki-1; D1S166E; tumor necrosis factor receptor superfamily member 8; Ki-1 antigen; CD30L receptor; cytokine receptor CD30; lymphocyte activation antigen CD30;
- Target Entrez Gene ID
- 943
- Target UniProt ID
- A5D8T4
- Overview
- The protein encoded by this gene is a member of the TNF-receptor superfamily. This receptor is expressed by activated, but not by resting, T and B cells. TRAF2 and TRAF5 can interact with this receptor, and mediate the signal transduction that leads to the activation of NF-kappaB. This receptor is a positive regulator of apoptosis, and also has been shown to limit the proliferative potential of autoreactive CD8 effector T cells and protect the body against autoimmunity. Two alternatively spliced transcript variants of this gene encoding distinct isoforms have been reported.
- Overview
- Chimeric Anti-TNFRSF8 Antibody, cAC10
- Generic name
- cAC10
- Species Reactivity
- Human
- Name
- β-glucuronide linker
- Description
- β-Glucuronide linkers belong to Enzymatically cleavable linkers, which have expected stability and provide facile release of the active drug. The cleavage of the β-glucuronide glycosidic bond relies on lysosomal enzyme β-glucuronidase, and this enzyme is abundantly present within lysosomes and is overexpressed in some tumor types, while the enzyme activity outside cells is low.
- Name
- MMAF (Monomethyl auristatin F)
- Description
- Derived from Auristatin,are water-soluble dolastatin analogs of dolastatin 10. Dolastatin 10 belongs to dolastatin family and it can powerfully bind to tubulin, thus inhibiting polymerization mediated through the binding to the vinca alkaloid binding domain, and causes cell to accumulate in metaphase arrest.
For Research Use Only. NOT FOR CLINICAL USE.
Related Products
- Anti-ST8SIA1 (Mitumomab)-MC-MMAF ADC (CAT#: ADC-W-1780)
- Anti-CTLA4 (Ipilimumab)-MC-Vc-PAB-SN38 ADC (CAT#: ADC-W-1002)
- Anti-IL22 (Fezakinumab)-MC-Vc-PAB-MMAE ADC (CAT#: ADC-W-1343)
- Anti-TAG-72 (Minretumomab)-MC-MMAF ADC (CAT#: ADC-W-1990)
- Anti-Fibrin II-beta chain (Biciromab)-SMCC-DM1 ADC (CAT#: ADC-W-1994)
- Anti-EGFR (ABT-806)-Mc-MMAF ADC (CAT#: ADC-W-515)
- Anti-KIRD2 (lirilumab)-MC-Vc-PAB-MMAE ADC (CAT#: ADC-W-2081)
- Anti-MS4A1 (Ocrelizumab)-MC-Vc-PAB-SN38 ADC (CAT#: ADC-W-1578)
- Anti-FOLH1 (Farletuzumab)-SMCC-DM1 ADC (CAT#: ADC-W-1166)
- Anti-CEACAM6 (Sulesomab)-MC-Vc-PAB-SN38 ADC (CAT#: ADC-W-978)
Published Data
+ Submit Publications
Scientific Resources
Customer Reviews and FAQs
There are currently no Customer reviews or questions for ADC-W-352. Click the button above to contact us or submit your feedback about this product.
Quick Links
Other Products
Same Target
Same Linker
Same Payload
| CAT# | Product Name | Linker | Payload |
| ADC-W-1890 | Anti-TNFRSF8 (Iratumumab)-MC-Vc-PAB-SN38 ADC | MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | SN-38 (7-ethyl-10-hydroxycamptothecin) |
| ADC-W-1891 | Anti-TNFRSF8 (Iratumumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC | MC-Vc-PAB-DMEA-(PEG2) | duocarmycin SA |
| ADC-W-2344 | Anti-TNFRSF8 (Brentuximab )-SPDB-DM4 ADC | SPDB (N-succinimidyl-4-(2-pyridyldithio)butyrate) | DM4 (N2'-Deacetyl-N2'-(4-mercapto-4-methyl-1-oxopentyl)maytansine) |
| ADC-W-355 | Anti-TNFRSF8 (cAC10)-Mc-MMAF ADC | MC-VC-PABC (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | MMAF (Monomethyl auristatin F) |
| ADC-W-1886 | Anti-TNFRSF8 (Iratumumab)-SMCC-DM1 ADC | SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate) | DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine) |
| CAT# | Product Name | Linker | Payload |
| ADC-W-373 | Anti-CD70 (clone h1F6)-β-glucuronide-CBI Minor Groove Binder ADC | β-glucuronide linker | CBI Minor Groove Binder |
| ADC-W-353 | Anti-TNFRSF8 (cCA10)-β-glucuronide-doxorubicin propyloxazoline (DPO) ADC | β-glucuronide linker | doxorubicin propyloxazoline (DPO) |
| ADC-W-376 | Anti-CD70 (clone h1F6)-β-glucuronide-doxorubicin ADC | β-glucuronide linker | doxorubicin |
| ADC-W-350 | Anti-TNFRSF8 (CA10)-β-glucuronide-CBI Minor Groove Binder ADC | β-glucuronide linker | CBI Minor Groove Binder |
| ADC-W-372 | Anti-CD70 (clone h1F6)-β-glucuronide-Camptothecin Analog ADC | β-glucuronide linker | Camptothecin Analog |
| CAT# | Product Name | Linker | Payload |
| ADC-AA-028 | anti-MIgG(Fc)Fab-C-MMAF ADC | Cleavable linkers | MMAF (Monomethyl auristatin F) |
| ADC-AA-049 | Protein G-MMAF ADC | MMAF (Monomethyl auristatin F) | |
| ADC-W-537 | Anti-TPBG-Mc-MMAF ADC | Mc (maleimidocaproyl) | MMAF (Monomethyl auristatin F) |
| ADC-W-493 | Anti-CD19 (clone huB4)-Mc-MMAF ADC | Mc (maleimidocaproyl) | MMAF (Monomethyl auristatin F) |
| ADC-AA-009 | anti-HIgG(Fc)Fab-N-MMAF ADC | Noncleavable linkers | MMAF (Monomethyl auristatin F) |
Online Inquiry
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.
